Related Experiment Video
Updated: Sep 12, 2025

Experimental Model to Evaluate Resolution of Pneumonia
Published on: February 17, 2023
Risk prediction models for mortality in patients with severe pneumonia: a systematic review and meta-analysis
Xiaoyu Wang1,2, Zhenzhen Feng1,2,3, Lu Wang1,2
1Department of Respiratory Diseases, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, Henan, China.
Background:
The number of risk prediction models for mortality in patients with severe pneumonia (SP) is increasing, while the quality and clinical applicability of these models remain unclear. This study aimed to systematically review published research on risk prediction models for mortality in patients with SP.
Methods:
PubMed, Embase, Cochrane Library, and Web of Science were searched from inception to August 31, 2024. Data from selected studies were extracted, including study design, participants, diagnostic criteria, sample size, predictors, model development, and performance. The prediction model risk of bias assessment tool was used to assess the risk of bias and applicability. A meta-analysis of the area under the curve (AUC) values from validated models was conducted using Stata 17.0 software.
Results:
A total of 22 prediction models from 18 studies were included in this review, including 15 logistic regression models, two cox proportional regression hazards models, two classification and regression trees, one light gradient boosting machine, and one multilayer perceptron. The reported AUC values ranged from 0.713 to 0.952. Seventeen studies were found to have a high risk of bias, primarily due to inappropriate data sources and poor reporting of the analysis domain. The pooled AUC value of five validated models was 0.85 (95% confidence interval: 0.81-0.88), indicating a fair level of discrimination.
Conclusion:
Although the included studies reported that the risk prediction models for mortality in patients with SP exhibited a certain level of discriminative ability, most of these models were found to have a high risk of bias. Future studies should focus on developing new models with larger sample sizes, rigorous study designs, and multicenter external validation.
Systematic Review Registration:
https://www.crd.york.ac.uk/PROSPERO/view/CRD42024589877, identifier: CRD42024589877.
More Related Videos
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
06:19Constructing and Visualizing Models using Mime-based Machine-learning Framework
Published on: July 22, 2025
Related Concept Videos
Pneumonia III: Complications and Assessment
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia II: Pathophysiology
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care